Regeneron Pharmaceuticals
REGN
REGN
623 hedge funds and large institutions have $25B invested in Regeneron Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 240 increasing their positions, 211 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.19% more ownership
Funds ownership: 68.47% → 68.66% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
37% less call options, than puts
Call options by funds: $566M | Put options by funds: $893M
Holders
623
Holding in Top 10
12
Calls
$566M
Puts
$893M
Top Buyers
| 1 | +$500M | |
| 2 | +$470M | |
| 3 | +$184M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$167M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$70.1M |
Top Sellers
| 1 | -$309M | |
| 2 | -$204M | |
| 3 | -$189M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$123M |
| 5 |
D.E. Shaw & Co
New York
|
-$115M |